OOIR: Observatory of International Research

Papers

(The median citation count of Journal of Clinical and Translational Hepatology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
The Impact of Liver Graft Preservation Method on Longitudinal Gut Microbiome Changes Following Liver Transplant: A Proof-of-concept Study	111
Comparison of Clinical Characteristics and Outcomes of MAFLD and NAFLD in Chinese Health Examination Populations	88
Evaluation of Plasma Neurodegenerative Biomarkers for Diagnosing Minimal Hepatic Encephalopathy and Predicting Overt Hepatic Encephalopathy in Chinese Patients with Hepatic Cirrhosis	60
GPX4 Promoter Hypermethylation Induced by Ischemia/Reperfusion Injury Regulates Hepatocytic Ferroptosis	40
1,5-Anhydroglucitol Predicts Mortality in Patients with HBV-Related Acute-on-chronic Liver Failure	33
Development and Validation of a Nomogram for Prediction of the Risk of MAFLD in an Overweight and Obese Population	33
Epidemiology, Achievements, and Challenges in the Elimination of Hepatitis B in China	31
Development and Validation of a Novel Noninvasive Model to Predict Liver Fibrosis Staging in Untreated Patients with Chronic Hepatitis B	27
The Gut Microbiota in Elderly Patients with Acute Hepatitis E Infection	25
CEACAM-1 Induced CSF3-receptor Downregulation in Bone Marrow Associated With Refractory Neutropenia in Advanced Cirrhosis	25
Expert Consensus on Clinical Applications of Fecal Microbiota Transplantation for Chronic Liver Disease (2025 edition)	25
Fas/FasL and Complement Activation are Associated with Chronic Active Epstein-Barr Virus Hepatitis	24
Clinical Significance of Apurinic/Apyrimidinic Endodeoxyribonuclease 1 and MicroRNA Axis in Hepatocellular Carcinoma	24
Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma	24
Tumor-associated Exosomes Are Involved in Hepatocellular Carcinoma Tumorigenesis, Diagnosis, and Treatment	21
Subnormal Serum Liver Enzyme Levels: A Review of Pathophysiology and Clinical Significance	21
Selecting an Appropriate Experimental Animal Model for Cholangiocarcinoma Research	21
Progress in the Correlation Between Inflammasome NLRP3 and Liver Fibrosis	20
Oncolytic Virus Senecavirus A Inhibits Hepatocellular Carcinoma Proliferation and Growth by Inducing Cell Cycle Arrest and Apoptosis	20
Role of Hydrogen Sulfide and Hypoxia in Hepatic Angiogenesis of Portal Hypertension	19
Transcriptomic Landscape Analysis Reveals a Persistent DNA Damage Response in Metabolic Dysfunction-associated Steatohepatitis Post-dietary Intervention	19
Ferrochelatase Gene Variants Associated with Cholestasis in Adults: A Case Report	18
Decoding 17-Beta-hydroxysteroid Dehydrogenase 13: A Multifaceted Perspective on Its Role in Hepatic Steatosis and Associated Disorders	17
Heterotopic Auxiliary Liver Transplantation in a Child with Portal Hypertension Using a Discarded Partial Right Liver Allograft from an Adult Patient with Alveolar Echinococcosis	17
Chinese Clinical Practice Guidelines for the Prevention and Treatment of Mother-to-child Transmission of Hepatitis B Virus (Version 2024)	17

Premorbid Steatohepatitis Increases the Seriousness of Dextran Sulfate Sodium-induced Ulcerative Colitis in Mice	17
Booster Vaccination in Infancy Reduces the Incidence of Occult HBV Infection in Maternal HBsAg-positive Children	16
Dose-dependent Relationship between Alcohol Consumption and the Risks of Hepatitis B Virus-associated Cirrhosis and Hepatocellular Carcinoma: A Meta-analysis and Systematic Review	16
Role of Exosomal Modulation of Macrophages in Liver Fibrosis	16
Efficacy and Safety of Aspirin for Prevention of Hepatocellular Carcinoma: An Updated Meta-analysis	16
Fecal Microbiome and Bile Acid Profiles Differ in Preterm Infants with Parenteral Nutrition-associated Cholestasis	16
Inflammation and Mitochondrial Dysfunction in Cirrhotic Cardiomyopathy: Therapeutic Implications	16
FOXO1 Alleviates Liver Ischemia-reperfusion Injury by Regulating the Th17/Treg Ratio through the AKT/Stat3/FOXO1 Pathway	16
SGLT-2 Inhibitor and GLP-1 Receptor Agonist Treatment for Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Is Their Combination the Optimal Treatment Option?	16
Ursodeoxycholic Acid for the Management of Drug-induced Liver Injury: Role of Hepatoprotective and Anti-cholestatic Mechanisms	15
A Prognostic Nomogram for Hepatocellular Carcinoma Based on Wound Healing and Immune Checkpoint Genes	15
Gut Microbiota and Cytokine Profile in Cirrhosis	14
Relationship between the Level of Serum Golgi Protein 73 and the Risk of Short-term Death in Patients with ALD-ACLF	13
Journal of Clinical and Translational Hepatology 10^th Anniversary Editorial	13
SOX9 Overexpression Ameliorates Metabolic Dysfunction-associated Steatohepatitis Through Activation of the AMPK Pathway	13
Single-cell RNA-seq Revealed that Altered Tumor Infiltrating Lymphocytes in Cirrhotic Liver Indicate Development of Hepatocellular Carcinoma	13
Characteristics of a Chinese Cohort of Patients with Chronic Hepatitis C Infection (2019–2023) and a Case Report of Resistance-associated Substitutions to Sofosbuvir-velpatasvir Treatment	13
The Role of Mitochondrial Complexes in Liver Diseases	13
Hepatocellular Carcinoma with Gastric Metastasis Mimicking a 4 cm Gastrointestinal Stromal Tumor After a 3-year Disease-free Interval	13
Nonalcoholic Fatty Liver Disease and the Intestinal Microbiome: An Inseparable Link	13
Characteristics of Drug-induced Liver Injury in Chronic Liver Disease: Results from the Thai Association for the Study of the Liver (THASL) DILI Registry	12
Complete Resolution of Refractory Ascites and Pleural Effusion with Sustained Improvement in Urinary Sodium Excretion in a Cirrhotic Patient Treated with Empagliflozin	12
Overexpression of Hepcidin Alleviates Steatohepatitis and Fibrosis in a Diet-induced Nonalcoholic Steatohepatitis	12
Hepatocellular Carcinoma and the Role of Liver Transplantation: An Update and Review	12
Ferroptosis and Intrinsic Drug-induced Liver Injury by Acetaminophen and Other Drugs: A Critical Evaluation and Historical Perspective	11
Associations Between Active, Passive Smoking and the Risk of Nonalcoholic Fatty Liver Disease	11
Noninvasive Fibrosis Assessment in Chronic Hepatitis C Infection: An Update	11
Hydrogen Sulfide Promotes Platelet Autophagy via PDGFR-α/PI3K/Akt Signaling in Cirrhotic Thrombocytopenia	11
Late-onset Cholestasis with Paucity of Portal Area Secondary to HNF1β Deficiency in Adulthood: A Case Report	11
MALAT1-mediated EZH2 Recruitment to the GFER Promoter Region Curbs Normal Hepatocyte Proliferation in Acute Liver Injury	11
Surveillance Imaging and GAAD/GALAD Scores for Detection of Hepatocellular Carcinoma in Patients with Chronic Hepatitis	11
Mesenchymal Stem Cells Alleviate Acute Liver Failure through Regulating Hepatocyte Apoptosis and Macrophage Polarization	11
Secondary Iron Overload and the Liver: A Comprehensive Review	11
Peripheral Blood CD4⁺/CD8⁺ T Cell Ratio Predicts HBsAg Clearance in Inactive HBsAg Carriers Treated with Peginterferon Alpha	10
Impaired Pulmonary Function as a Potential Contributor to Reduced Exercise Capacity Associated with MAFLD	10
Severe Acute Hepatitis of Unknown Origin in Children: What Do We Know Today?	10
Establishment and Validation of a Four-stress Granule-related Gene Signature in Hepatocellular Carcinoma	10
Emerging Therapeutic Strategies in the Fight Against Primary Biliary Cholangitis	10
Noninvasive Assessment of Liver Fibrosis and Inflammation in Chronic Hepatitis B: A Dual-task Convolutional Neural Network (DtCNN) Model Based on Ultrasound Shear Wave Elastography	10
Corrigendum: Osteopontin Promotes Macrophage M1 Polarization by Activation of the JAK1/STAT1/HMGB1 Signaling Pathway in Nonalcoholic Fatty Liver Disease	10
Dynamic Humoral Immune Response to Primary and Booster Inactivated SARS-CoV-2 Vaccination in Patients with Cirrhosis	10
Dissecting the Contributing Role of Divergent Adipose Tissue to Multidimensional Frailty in Cirrhosis	10
Arctigenin Prevents Metabolic Dysfunction-associated Steatohepatitis by Inhibiting NLRP3/GSDMD-N Axis in Macrophages	9
Pipeline of New Drug Treatment for Non-alcoholic Fatty Liver Disease/Metabolic Dysfunction-associated Steatotic Liver Disease	9
Exploring Circulating Tumor Cells: Detection Methods and Biomarkers for Clinical Evaluation in Hepatocellular Carcinoma	9
FTO Promotes Hepatocellular Carcinoma Progression by Mediating m6A Modification of BUB1 and Targeting TGF-βR1 to Activate the TGF-β Signaling Pathway	9
Prognostic Performance of the China Liver Cancer Staging System in Hepatocellular Carcinoma Following Transarterial Chemoembolization	9
Guidelines for the Management of Cholestatic Liver Diseases (2021)	9
Fucoidan Ameliorates Ferroptosis in Ischemia-reperfusion-induced Liver Injury through Nrf2/HO-1/GPX4 Activation	9
Chinese Expert Consensus for the Management of Thrombocytopenia in Cirrhosis	9

Progress in Biomarkers Related to Biliary Atresia	9
Management Algorithm for Prevention of Mother-to-child Transmission of Hepatitis B Virus (2022)	9
Molecular and Histological Profiles and Relevant Imaging Signatures of Intrahepatic Cholangiocarcinoma	8
Alcoholic vs. Nonalcoholic Steatohepatitis: Vascular Branching Heterogeneity on Magnetic Resonance Imaging as a Diagnostic Marker	8
Time of Liver Function Abnormal Identification on Prediction of the Risk of Anti-tuberculosis-induced Liver Injury	8
Prognostic Impact of Surgical Margin Width in Hepatectomy for Colorectal Liver Metastasis	8
The Therapeutic Effects of Baicalein on the Hepatopulmonary Syndrome in the Rat Model of Chronic Common Bile Duct Ligation	8
Efficacy of Vaccine Protection Against COVID-19 Virus Infection in Patients with Chronic Liver Diseases	8
Stratified Analysis of Survival Benefit for ABO-incompatible Deceased-donor Liver Transplantation: Multicenter Propensity Score-matched Study	8
Therapeutic Perspectives of IL1 Family Members in Liver Diseases: An Update	8
Portal Fibrotic Cord is Associated with Transjugular Intrahepatic Portosystemic Shunt Failure and Death in Cirrhotic Patients	8
A Prognostic Nomogram with High Accuracy Based on 2D-SWE in Patients with Acute-on-chronic Liver Failure	8
DysUFMylation of SREBP1 Promotes the Progression of Hepatocellular Carcinoma by Reprogramming Lipid Metabolism	8
Prognostic Nutritional Index Predicts Outcomes in Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab: A Propensity Score-matched Analysis	8
Exploring the Pathogenesis of Autoimmune Liver Diseases from the Heterogeneity of Target Cells	7
Interim Analysis of 48-week Tenofovir Amibufenamide Treatment in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase Levels: The PROMOTE Study	7
Investigating the Effect of Metabolic Phenotypes on Health Events in Alcoholic and Nonalcoholic Fatty Liver Disease	7
Corrigendum: Ursolic Acid Modulates Estrogen Conversion to Relieve Inflammation in Metabolic Dysfunction-associated Steatotic Liver Disease via HSD17B14	7
Prognostic Relevance of Metabolic Dysfunction-associated Steatohepatitis for Patients with Chronic Hepatitis B	7
Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis	7
Differentiating Neonatal Dubin Johnson Syndrome from Biliary Atresia: Start Simply	7
Systematic Evaluation of Guidelines for the Diagnosis and Treatment of Hepatitis E Virus Infection	7
Recent Progress and Future Direction for the Application of Multiomics Data in Clinical Liver Transplantation	7
Current and Emerging Issues in Familial Hypobetalipoproteinemia-related Steatotic Liver Diseases	7
MELD or MELD-Na as a Predictive Model for Mortality Following Transjugular Intrahepatic Portosystemic Shunt Placement	7
Effects of Transjugular Intrahepatic Portosystemic Shunt on Renal and Pulmonary Function in Hepatic Decompensation with and without Hepatorenal and Hepatopulmonary Syndromes: A Review	7
Global Prevalence, Temporal Trends, and Associated Mortality of Bacterial Infections in Patients with Liver Cirrhosis: A Meta-analysis	7
Development of a Widely Applicable and Simple Prognostic Score for Patients with Acute-on-chronic Liver Failure	6
Immune Regulatory Networks and Therapy of γδ T Cells in Liver Cancer: Recent Trends and Advancements	6
Research Progress on Leptin in Metabolic Dysfunction-associated Fatty Liver Disease	6
The Role of Solute Carrier Family Transporters in Hepatic Steatosis and Hepatic Fibrosis	6
Diagnostic and Prognostic Value of Protein Post-Translational Modifications in Hepatocellular Carcinoma	6
Reactive Oxygen Species and Oxidative Stress in the Pathogenesis of MAFLD	6
Transjugular Intrahepatic Portosystemic Shunt Linked to Increased Risk of Hepatocellular Carcinoma: A VA Matched Cohort Study	6
Antiviral Therapy Favors a Lower Risk of Liver Cirrhosis in HBeAg-negative Chronic Hepatitis B with Normal Alanine Transaminase and HBV DNA Positivity	6
Prognostic Biomarkers for Hepatocellular Carcinoma Based on Serine and Glycine Metabolism-related Genes	6
Emerging Serum Biomarkers for Chronic Hepatitis B: Focus on Serum HBV RNA and HBcrAg	6
Cumulative Hepatitis B Surface Antigen/Hepatitis B Virus DNA Ratio in Immune-tolerant Hepatitis B Patients: A 10-year Follow-up Study	6
Liver Lesions at Risk of Transformation into Hepatocellular Carcinoma in Cirrhotic Patients: Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement	6
Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment	6
Multifaceted Influence of Histone Deacetylases on DNA Damage Repair: Implications for Hepatocellular Carcinoma	6
Corrigendum: RP11-40C6.2 Inactivates Hippo Signaling by Attenuating YAP1 Ubiquitylation in Hepatitis B Virus-associated Hepatocellular Carcinoma	5
Evaluation of Ultrasound-based Surveillance for Hepatocellular Carcinoma in Patients at Risk: Results From a German Multicenter Retrospective Cohort Study	5
Plasma Extracellular Vesicle-derived MicroRNA Associated with Human Alpha-1 Antitrypsin Deficiency-mediated Liver Disease	5
Carvedilol Versus Other Nonselective Beta Blockers for Variceal Bleeding Prophylaxis and Death: A Network Meta-analysis	5
GTF3C2 Promotes the Proliferation of Hepatocellular Carcinoma Cells through the USP21/MEK2/ERK1/2 Pathway	5
Causal Relationship Between Gut Microbiota and Liver Cirrhosis: 16S rRNA Sequencing and Mendelian Randomization Analyses	5
Evaluation of Preoperative Microvascular Invasion in Hepatocellular Carcinoma Through Multidimensional Parameter Combination Modeling Based on Gd-EOB-DTPA MRI	5
High Frequency of Antiviral Resistance Mutations in HBV Genotypes A2 and H: Multidrug Resistance Strains in Mexico	5
Acute Hepatitis of Unknown Origin in Children: Early Observations from the 2022 Outbreak	5
Serum Iron Overload Activates the SMAD Pathway and Hepcidin Expression of Hepatocytes via SMURF1	5
Establishment of a Rat Model of Liver Venous Deprivation: Simultaneous Portal and Hepatic Vein Ligation	5
Global Trends and Cross-country Inequalities of Acute Hepatitis E in the Elderly, 1990–2021: A Comprehensive Analysis	5
Value of Non-tumoral Liver Volume in the Prognosis of Large Hepatocellular Carcinoma Patients After R0 Resection	5
Augmenter of Liver Regeneration Monoclonal Antibody Promotes Apoptosis of Hepatocellular Carcinoma Cells	5
MgIG Attenuates Oxaliplatin-induced Hepatotoxicity through Suppression of Connexin 43 in Hepatic Stellate Cells	5
Comprehensive Approach to Assessment of Liver Viability During Normothermic Machine Perfusion	5
Therapeutic Use of Viruses: Newcastle Disease Virus HK84 Oncolytic Treatment for Hepatocellular Carcinoma	5
Distinct Types of Cell Death and Implications in Liver Diseases: An Overview of Mechanisms and Application	5
Regional and National Trends of Adult Living Donor Liver Transplantation in the United States Over the Last Two Decades	5
Development and Validation of a Clinical Risk Score to Predict Immune-mediated Liver Injury Caused by Sintilimab: Assessed for Causality Using Updated RUCAM	5
2022 Reviewer Acknowledgement	5
Immunotherapy-induced Hepatotoxicity: A Review	5
Peptidomic Analysis Reveals that Novel Peptide LDP2 Protects Against Hepatic Ischemia/Reperfusion Injury	4
Oxytocin Attenuates Metabolic Dysfunction-associated Steatotic Liver Disease via AMPK/SREBP1c/FAS-mediated Suppression of Hepatic Lipogenesis	4
Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Current Progresses and Challenges	4
COVID-19 and Liver Transplantation: Challenges and Opportunities	4
Trends of Cirrhosis-related Mortality in the USA during the COVID-19 Pandemic	4
RP11-40C6.2 Inactivates Hippo Signaling by Attenuating YAP1 Ubiquitylation in Hepatitis B Virus-associated Hepatocellular Carcinoma	4
Performance of Hepatitis Delta Virus (HDV) RNA Testing for the Diagnosis of Active HDV Infection: Systematic Review and Meta-analysis	4
Hepatosplenic Volumes and Portal Pressure Gradient Identify One-year Further Decompensation Risk Post-transjugular Intrahepatic Portosystemic Shunt	4
Infections in Alcoholic Hepatitis	4
Safety and Immunogenicity After Primary and Booster Inactivated SARS-Cov-2 Vaccination in Patients with Autoimmune Liver Diseases	4
New Staging Model for Radiation-based Hepatocellular Carcinoma Treatment: A National Multicenter Study	4
Combination Therapies for Advanced Biliary Tract Cancer	4
Corrigendum: Transjugular Intrahepatic Portosystemic Shunt Linked to Increased Risk of Hepatocellular Carcinoma: A VA Matched Cohort Study	4
Sarmentosin Induces Autophagy-dependent Apoptosis via Activation of Nrf2 in Hepatocellular Carcinoma	4
Unraveling the Emerging Niche Role of Hepatic Stellate Cell-derived Exosomes in Liver Diseases	4
Pre-emptive TIPSS in Acute Variceal Bleeding: Current Status, Controversies, and Future Directions	4
Corrigendum: Liver Characterization of a Cohort of Alpha-1 Antitrypsin Deficiency Patients with and without Lung Disease	4

Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Hepatitis B: Protocol for a Phase 3 Randomized Trial	4
Clinical Characteristics, Treatment Effects and Risk Factors of Liver Cirrhosis in Patients with Wilson’s Disease Hepatic Type	4
Advances in the Treatment of Autoimmune Hepatitis	4
Serum Soluble Vascular Endothelial Growth Factor Receptor 1 as a Potential Biomarker of Hepatopulmonary Syndrome	4
Intrahepatic Cholestasis of Pregnancy: A Hot Topic Commentary	4
ADAMTS13 Improves Hepatic Platelet Accumulation in Pyrrolizidine Alkaloids-induced Liver Injury	4
Defining the Value of Extracorporeal Liver Support in Acute and Acute-on-chronic Liver Failure	4
Discrepancies between Nonalcoholic and Metabolic-associated Fatty Liver Disease by Multiple Steatosis Assessment	4
Identification and Analysis of Gut Microbiota and Functional Metabolism in Decompensated Cirrhosis with Infection	4
Upregulation of TMCO3 Promoting Tumor Progression and Contributing to the Poor Prognosis of Hepatocellular Carcinoma	4
Centromere Protein I, a Cell Cycle Checkpoint Gene, Accelerates Tumor Progression via the Hippo Pathway and Mediates Immune Escape in Hepatocellular Carcinoma	4
Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review	4
New First-line Immunotherapy-based Therapies for Unresectable Hepatocellular Carcinoma: A Living Network Meta-analysis	4
Pregnancy and Metabolic-associated Fatty Liver Disease: A Clinical Update	4
Genotype-specific Response to 144-week Entecavir Therapy for HBeAg-positive Chronic Hepatitis B with a Particular Focus on Histological Improvement: A Prospective Study	4
The Relationship between Viral Replication and the Severity of Hepatic Necroinflammatory Damage Changed before HBeAg Loss in Patients with Chronic Hepatitis B Virus Infection	4
Guidelines for the Management of Esophagogastric Variceal Bleeding in Cirrhotic Portal Hypertension	4
Spindle and Kinetochore-associated Family Genes are Prognostic and Predictive Biomarkers in Hepatocellular Carcinoma	4
Acute Severe Hepatitis of Unknown Origin in Children Across the World: A 2022 Source of Concern	4
Prevalence of Hepatitis D Virus Antibody Positivity in Chinese Patients with Chronic Hepatitis B Virus Infection	4
Association between Metabolic Dysfunction-associated Fatty Liver Disease and Cognitive Impairment	3
Pluripotent Stem Cell-derived Strategies to Treat Acute Liver Failure: Current Status and Future Directions	3
The Rising Burden of Hepatocellular Carcinoma: Is the Gender Gap Narrowing?	3
Artesunate Induces Ferroptosis in Hepatic Stellate Cells and Alleviates Liver Fibrosis via the ROCK1/ATF3 Axis	3
Transplantation of Mesenchymal Stem Cells Attenuates Acute Liver Failure in Mice via an Interleukin-4-dependent Switch to the M2 Macrophage Anti-inflammatory Phenotype	3
Protective Effect of Mesaconate on Autoimmune Hepatitis via Suppression of Inflammatory Response and Oxidative Stress	3
An-Luo-Hua-Xian Pill Improves the Regression of Liver Fibrosis in Chronic Hepatitis B Patients Treated with Entecavir	3
Novel Approaches to Inhibition of HBsAg Expression from cccDNA and Chromosomal Integrants: A Review	3
Acute Liver Failure with Determinate rather than Indeterminate Etiology Facilitates Therapy and May Avoid Liver Transplantation: A Critical Analysis	3
High Levels of Vitamin C Intake Modify Effects of Phthalates on Metabolic Dysfunction-associated Steatotic Liver Disease: A Nationally Representative Study	3
Soluble CD163 and CD163 Expression on Monocytes Associated with Chronic Hepatitis B Inflammation and HBsAg Loss	3
Clinical Predictors of Functional Cure in Children 1–6 Years-old with Chronic Hepatitis B	3
NASH Drug Development: Seeing the Light at the End of the Tunnel?	3
Intestinal Depletion of TM6SF2 Exacerbates High-fat Diet-induced Metabolic Dysfunction-associated Steatotic Liver Disease through the Gut-liver Axis	3
Sending an SOS: Healing the Liver with the Bone Marrow	3
A Blood Hepatocellular Carcinoma Signature Recognizes Very Small Tumor Nodules with Metastatic Traits	3
Serum Interleukin-8 for Differentiating Invasive Pulmonary Aspergillosis from Bacterial Pneumonia in Patients with HBV-Associated Acute-on-Chronic Liver Failure	3
Mechanism of Metabolic Dysfunction-associated Steatotic Liver Disease: Important role of lipid metabolism	3
CCNE1 Promotes the Progression of Hepatic Precancerous Lesion and the Malignant Phenotype of Hepatocellular Carcinoma	3
PDK4 Regulates Inflammatory Injury in Acute-on-chronic Liver Failure by Phosphorylating STAT1-mediated M1 Polarization of Macrophages	3
Comprehensive Bile Acid Profiling of ABCB4-mutated Patients and the Prognostic Role of Taurine-conjugated 3α,6α,7α,12α-Tetrahydroxylated Bile Acid in Cholestasis	3
ATOX1 Promotes Hepatocellular Carcinoma Carcinogenesis via Activation of the c-Myb/PI3K/AKT Signaling Pathway	3
TDF Promotes Glycolysis and Mitochondrial Dysfunction to Accelerate Lactate Accumulation by Downregulating PGC1α in Mice	3
Update on Sphincter of Oddi Dysfunction: A Review	3
“Treat-all” Strategy for Patients with Chronic Hepatitis B Virus Infection in China: Are We There Yet?	3
Key Points and Future Directions from the 2024 Chinese Guidelines for Fatty Liver Disease	3
Hepatocellular Ballooning is Due to Highly Pronounced Glycogenosis Potentially Associated with Steatosis and Metabolic Reprogramming	3
Efficacy and Safety of Sofosbuvir-based Regimens in Hepatitis C Patients With Decompensated Cirrhosis: A Systematic Review and Meta-analysis	3
Topoisomerase I Inhibition Radiosensitizing Hepatocellular Carcinoma by RNF144A-mediated DNA-PKcs Ubiquitination and Natural Killer Cell Cytotoxicity	3
Fluorescence-guided Surgery for Hepatocellular Carcinoma: From Clinical Practice to Laboratories	3
Protein Induced by Vitamin K Absence or Antagonist II in Primary Liver Cancer: Basic Research Insights and Clinical Applications	3
Trends in Mortality of Cirrhosis in China: An Analysis of the China Death Surveillance Database from 2008 to 2020	3
Pediatric Acute Severe Hepatitis of Unknown Origin: What is New?	2
CD55 Variant Associated with Pegylated-interferon α Therapy Response in HBeAg-positive Chronic Hepatitis B Patients	2
Nutrient-stimulated Hormone-based Therapies: A New Frontier in the Prevention and Management of MASH-associated Hepatocellular Carcinoma	2
Mouse Models for the Study of Liver Fibrosis Regression In Vivo and Ex Vivo	2
Integrated Analysis of Serum and Fecal Metabolites Reveals the Role of Bile Acid Metabolism in Drug-induced Liver Injury: Implications for Diagnostic and Prognostic Biomarkers	2
Efficacy and Economic Evaluation of Nonbiological Artificial Liver Therapy in Acute-on-chronic Hepatitis B Liver Failure	2
Emerging Roles of High-mobility Group Box-1 in Liver Disease	2
Hepatocellular Carcinoma Risk Scores from Modeling to Real Clinical Practice in Areas Highly Endemic for Hepatitis B Infection	2
2023 Reviewer Acknowledgement	2
Prevalence of Hepatitis B Core Antibody in Intravenous Immunoglobulin Products by Chemiluminescent Microparticle Immunoassay	2
Autoimmune Hepatitis Associated with Other Autoimmune Diseases: A Critical Review	2
Portal Hypertension in Nonalcoholic Fatty Liver Disease: Challenges and Paradigms	2
Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma: Real-life Data on Liver Disease, Treatment and Prognosis	2
Orphan Nuclear Receptors in Metabolic Dysfunction-associated Steatotic Liver Disease Development	2
Naringenin is a Potential Immunomodulator for Inhibiting Liver Fibrosis by Inhibiting the cGAS-STING Pathway	2
Krüppel-like Factor 13 Promotes HCC Progression by Transcriptional Regulation of HMGCS1-mediated Cholesterol Synthesis	2
Co-designing Approaches to Sustainable Exercise Care for People with Metabolic Dysfunction-associated Steatotic Liver Disease	2
HBeAg-negative Patients with Chronic Hepatitis B Virus Infection and Normal Alanine Aminotransferase: Wait or Treat?	2
Improved Discrimination and Predictive Ability of Novel Prognostic Scores for Long-term Mortality in Hospitalized Patients with Cirrhosis	2
Adjuvant Therapy for Hepatocellular Carcinoma After Curative Treatment: Several Unanswered Questions	2
Liver Injury in Immune Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Five New Classification Types	2
Pharmacotherapy for Non-alcoholic Fatty Liver Disease Associated with Diabetes Mellitus Type 2	2
Hepatocellular Carcinoma Incidence and Mortality in the USA by Sex, Age, and Race: A Nationwide Analysis of Two Decades	2
The Imbalance of Homeostasis in Neutrophil Extracellular Traps is Associated with Portal Vein Thrombosis in Patients with Decompensated Cirrhosis	2
Traditional and Novel Virologic Markers for Functional Cure and HBeAg Loss with Pegylated Interferon in Chronic Hepatitis B: A Systematic Review and Meta-analysis	2
Applications of Artificial Intelligence and Smart Devices in Metabolic Dysfunction-associated Steatotic Liver Disease	2
Genetics of Gallstone Disease and Their Clinical Significance: A Narrative Review	2
Impact of Proteinuria on Liver Enzyme Levels	2
BTF3L4 Overexpression Mediates APAP-induced Liver Injury in Mouse and Cellular Models	2
Role of Noncoding RNAs in the Tumor Immune Microenvironment of Hepatocellular Carcinoma	2
Breath Biopsy^® to Identify Exhaled Volatile Organic Compounds Biomarkers for Liver Cirrhosis Detection	2
Single-cell Technologies Provide Novel Insights into Liver Physiology and Pathology	2
Consensus on the Management of Liver Injury Associated with Targeted Drugs and Immune Checkpoint Inhibitors for Hepatocellular Carcinoma (Version 2024)	2
Risk of Coronary Artery Disease in Patients with Liver Cirrhosis: A Systematic Review and Meta-analysis	2
Ultrasonography of Hepatocellular Carcinoma: From Diagnosis to Prognosis	2
Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular Carcinoma	2
MRI/PAI Dual-modal Imaging-guided Precise Tracking of Bone Marrow-derived Mesenchymal Stem Cells Labeled with Nanoparticles for Treating Liver Cirrhosis	2
Direct-acting Antiviral-induced Transient Recovery of NK Cells in Early-stage Treatment of Chronic Hepatitis C Patients	2
Integrin α6 Targeted Near Infrared Fluorescent Imaging and Photoacoustic Imaging of Hepatocellular Carcinoma in Mice	2
Treatment Options for Hepatocellular Carcinoma Using Immunotherapy: Present and Future	2
CircTUBD1 Regulates Radiation-induced Liver Fibrosis Response via a circTUBD1/micro-203a-3p/Smad3 Positive Feedback Loop	2
Prognostic Factors Related to In-hospital Death in Children with Biliary Atresia: Analysis of a Nationwide Inpatient Database	2
Identification and Validation of the Hsa_circ_0001726/miR-140-3p/KRAS Axis in Hepatocellular Carcinoma Based on Microarray Analyses and Experiments	2